955 related articles for article (PubMed ID: 20142201)
21. Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis.
Ozawa M; Okamura A; Date M; Higuchi Y; Nagai H; Shibuya M; Ryusuke K; Inoue K; Koyama Y; Iwakura K; Fujii K
Catheter Cardiovasc Interv; 2012 Jan; 79(1):91-6. PubMed ID: 21452246
[TBL] [Abstract][Full Text] [Related]
22. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
23. Do drug elution components increase the risk of fracture of sirolimus-eluting stents?
Kawai T; Umeda H; Ota M; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Matsui S; Ishii J; Hishida H; Ozaki Y
Coron Artery Dis; 2010 Aug; 21(5):298-303. PubMed ID: 20617542
[TBL] [Abstract][Full Text] [Related]
24. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
[TBL] [Abstract][Full Text] [Related]
25. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
26. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
27. Late target lesion revascularization after implantation of sirolimus-eluting stent.
Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
[TBL] [Abstract][Full Text] [Related]
28. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study.
Chan C; Zambahari R; Kaul U; Lau CP; Whitworth H; Cohen S; Buchbinder M;
Catheter Cardiovasc Interv; 2008 Nov; 72(5):591-600. PubMed ID: 18949772
[TBL] [Abstract][Full Text] [Related]
30. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients.
Rathore S; Terashima M; Katoh O; Matsuo H; Tanaka N; Kinoshita Y; Kimura M; Tuschikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2009 Aug; 5(3):349-54. PubMed ID: 19736160
[TBL] [Abstract][Full Text] [Related]
31. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Shaikh F; Maddikunta R; Djelmami-Hani M; Solis J; Allaqaband S; Bajwa T
Catheter Cardiovasc Interv; 2008 Apr; 71(5):614-8. PubMed ID: 18360853
[TBL] [Abstract][Full Text] [Related]
32. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
Lee MS; Tarantini G; Xhaxho J; Yang T; Ehdaie A; Bhatia R; Favaretto E; Tobis J
JACC Cardiovasc Interv; 2010 Apr; 3(4):378-82. PubMed ID: 20398863
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
[TBL] [Abstract][Full Text] [Related]
36. Late restenosis following sirolimus-eluting stent implantation.
Kuriyama N; Kobayashi Y; Nakama T; Mine D; Nishihira K; Shimomura M; Nomura K; Ashikaga K; Matsuyama A; Shibata Y
JACC Cardiovasc Interv; 2011 Jan; 4(1):123-8. PubMed ID: 21251639
[TBL] [Abstract][Full Text] [Related]
37. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of a sirolimus-eluting stent (Cypher) for diffuse in-stent restenosis inside a bare metal stent.
Sakamoto H; Ishikawa T; Mutoh M; Okada H; Tsurusaki T; Ohta M; Higashitani M; Nakano Y; Fuda Y; Imai K; Horie T; Mochizuki S
Int Heart J; 2006 Sep; 47(5):651-61. PubMed ID: 17106136
[TBL] [Abstract][Full Text] [Related]
39. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
40. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]